Autor: |
Jon Dorling, Souvik Mitra, Ruben Alvaro, Jaideep Kanungo, Christine Drolet, Nadya Ben Fadel, Prakesh Shah, Xiang Y Ye, Amish Jain, Faiza Khurshid, Joseph Y. Ting, Miroslav Stavel, Ayman Abou Mehrem, Amuchou Soraisham, Bonny Jasani, Deepak Louis, Anie Lapointe, Abbas Hyderi, Kumar Kumaran, Jaya Bodani, Dany Weisz, Mohammed Adie, Alyssa Morin, Soume Bhattacharya, Rody Canning, Tara Hatfield, Courtney E Gardner |
Jazyk: |
angličtina |
Rok vydání: |
2021 |
Předmět: |
|
Zdroj: |
BMJ Open, Vol 11, Iss 5 (2021) |
Druh dokumentu: |
article |
ISSN: |
2044-6055 |
DOI: |
10.1136/bmjopen-2021-050682 |
Popis: |
Introduction Patent ductus arteriosus (PDA) is the most common cardiovascular problem that develops in preterm infants and evidence regarding the best treatment approach is lacking. Currently available medical options to treat a PDA include indomethacin, ibuprofen or acetaminophen. Wide variation exists in PDA treatment practices across Canada. In view of this large practice variation across Canadian neonatal intensive care units (NICUs), we plan to conduct a comparative effectiveness study of the different pharmacotherapeutic agents used to treat the PDA in preterm infants.Methods and analysis A multicentre prospective observational comparative-effectiveness research study of extremely preterm infants born |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|